InterDigital (NASDAQ: [[ticker:IDCC]]), a company that invents new wireless technologies and counts Samsung, Research in Motion, and HTC among its biggest customers, has opened a satellite R&D lab in San Diego. The new facility is initially focused on developing technologies to improve the capacity of wireless networks, according to Bill Merritt, the company’s CEO. Merritt, … Continue reading “InterDigital Opens San Diego Outpost in Quest to Ease “Bandwidth Crunch””
Category: National
Microsoft Gobbles Skype, Gamification’s Present and Future, Bill Gates on Clean Energy, & More in the Seattle-Area Tech Roundup
Microsoft’s blockbuster $8.5 billion deal to acquire Skype dominated headlines far beyond the Puget Sound region last week, raising all kinds of interesting implications for mobile computing, business communications, video games, and more. Many commenters were walloped by the sheer scope of Microsoft (NASDAQ: [[ticker:MSFT]]) products that Skype could be plugged into, but in our … Continue reading “Microsoft Gobbles Skype, Gamification’s Present and Future, Bill Gates on Clean Energy, & More in the Seattle-Area Tech Roundup”
The Man With The Golden Touch: Jeff Williams Eyes Triple Crown Of Sorts With Life Magnetics
If Jeff Williams has brewed some sort of secret concoction to converting local startups into big pay days, he’s not letting on. “You just make sure you develop good companies that people want to have,” the low key Williams tells Xconomy. “We were fortunate to have some nice exits.” That may be the understatement of … Continue reading “The Man With The Golden Touch: Jeff Williams Eyes Triple Crown Of Sorts With Life Magnetics”
Sign Up for Beyond Mobile: Computing in 2021, Before Time Runs Out
We’ve got 10 years to debate what computers will look like, and how they’ll work, in the year 2021. But you’ve only got one day left to sign up for Beyond Mobile: Computing in 2021, Xconomy San Francisco’s big spring infotech event at SRI International in Menlo Park, CA. I hope you won’t think I’m … Continue reading “Sign Up for Beyond Mobile: Computing in 2021, Before Time Runs Out”
SwipeGood, Lanyrd, Samsung, and PARC—The 1-Minute Version of Last Week’s Bay Area BizTech News
I spent a couple of days at the Google I/O developer conference in San Francisco last week, but unfortunately the news didn’t slow down to accommodate my absence from the office. —Our marquee infotech event of the spring, Beyond Mobile: Computing in 2021, is coming up tomorrow at SRI International in Menlo Park; you can … Continue reading “SwipeGood, Lanyrd, Samsung, and PARC—The 1-Minute Version of Last Week’s Bay Area BizTech News”
Medical Device Startup TransCorp Raises $700k+, Seeks $4M
TransCorp has raised $755,958 from the sale of equity, according to SEC documents. Overall, the medical device startup, based in Byron Center,MI, is seeking $4 million, the documents say. EDF Ventures in Ann Arbor, MI, Grand Angels in Holland, MI, and Hopen Life Science Ventures in Grand Rapids, MI, are backing the company. Founded by … Continue reading “Medical Device Startup TransCorp Raises $700k+, Seeks $4M”
Founder Labs Brings Its Silicon Valley Flair for Fostering Startups to Manhattan
Picking the right team can make all the difference when launching a new venture. Starting on May 21, a group of some 16 designers, engineers, and marketing professionals will gather to form teams aimed at creating startups. Founder Labs, a five week “pre-incubator” program targeting concepts for the mobile sector, is ready for its Manhattan … Continue reading “Founder Labs Brings Its Silicon Valley Flair for Fostering Startups to Manhattan”
Bill Gates’ Favorite Biofuel Company on the Docket for Thursday’s Alternative Fuels Event
There might be 100 good energy ideas in the U.S. today, as Bill Gates said last week at a fundraiser for Climate Solutions, but one of the really big ones he’s backing is San Diego-based Sapphire Energy. This company, which has raised more than $300 million to execute on its vision of making algae a … Continue reading “Bill Gates’ Favorite Biofuel Company on the Docket for Thursday’s Alternative Fuels Event”
Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug
[Updated: 8:55 am PT] Amylin Pharmaceuticals is hauling one of its big partners, Eli Lilly, into court. San Diego-based Amylin (NASDAQ: [[ticker:AMLN]]) said today it has filed a suit in the U.S. District Court for Southern California, that accuses Lilly of anticompetitive behavior and violating a 2002 agreement between the companies that covers the marketing … Continue reading “Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug”
Active Network Sets IPO Price Range, MIR3 Expands Platform, Qualcomm Collaborates on $10M Tricorder X Prize, & More San Diego BizTech News
It has taken about 12 years and more than $275 million in venture capital for San Diego’s Active Network to get into the starting gate for an IPO. We have details on that and the rest of San Diego’s tech news. —San Diego’s Active Network, which provides online registration services for sporting events and other … Continue reading “Active Network Sets IPO Price Range, MIR3 Expands Platform, Qualcomm Collaborates on $10M Tricorder X Prize, & More San Diego BizTech News”
Iron Mountain Sells Online Backup and Other Digital Businesses to Autonomy for $380M
Boston-based Iron Mountain, the data management and protection company, said today it is selling its online backup and recovery, digital archiving, and eDiscovery businesses to San Francisco- and Cambridge, U.K.-based Autonomy for $380 million in cash. The deal is expected to close within 45 to 60 days. Iron Mountain (NYSE: [[ticker:IRM]]), founded in 1951, is … Continue reading “Iron Mountain Sells Online Backup and Other Digital Businesses to Autonomy for $380M”
PacBio Chief Scientist Heads to NYC to Run New $100M Genomics Center at Mt. Sinai
Eric Schadt, one of the world’s top researchers looking at how changes in the genome lead to disease, is leaving his full-time job as chief scientist of Pacific Biosciences to spearhead a new genomics research center armed with more than $100 million of financial backing at Mt. Sinai School of Medicine in New York. This … Continue reading “PacBio Chief Scientist Heads to NYC to Run New $100M Genomics Center at Mt. Sinai”
The Resurgence of Gene and Cell Therapy
For those who have not been watching or involved, gene and cell therapy is experiencing a state of resurgence, driven by a series of positive achievements over the last three to four years. These are exciting times for those who kept the faith over the last two decades and pushed onward. There is buoyancy in … Continue reading “The Resurgence of Gene and Cell Therapy”
Lockerz’s Latest $30M Haul Easily Tops April’s List of Washington State Equity Deals
Let’s count the juicy consumer-Internet trends piled up in Seattle startup Lockerz: Social networking, photo sharing, gamification, deals, and original content. That’s a mouthful, and investors apparently like what they see—Lockerz’s $30 million venture round is by far the biggest equity deal in Washington state for the month of April, according to data compiled by … Continue reading “Lockerz’s Latest $30M Haul Easily Tops April’s List of Washington State Equity Deals”
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn?
Everywhere you look this spring, there are signs of bubbly enthusiasm for technology. Microsoft just paid $8.5 billion for a company that isn’t profitable. Facebook has racked up more than 600 million members around the world. LinkedIn is teed up to go public this week at a valuation of more than $3 billion. It may … Continue reading “Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn?”
$77M Merrimack Financing Helps April Startup Deals Soar to $306M
Things continued to warm up this spring for Massachusetts tech and life sciences startups inking investments. Last month, companies raised $306 million across 35 equity-based deals, a roughly 18 percent surge from during March. That’s according to data from our partner CB Insights’ FundingFlash, which provides a daily roundup of companies receiving venture capital, angel … Continue reading “$77M Merrimack Financing Helps April Startup Deals Soar to $306M”
PARC Fires Back at New Yorker, Claiming Old Apple Legend Misses Point of How Innovation Works Today
Three staff members at PARC, aka Xerox’s Palo Alto Research Center, have published a feisty response to Malcolm Gladwell’s May 16 New Yorker article, “Creation Myth: Xerox PARC, Apple, and the Truth about Innovation.” In short, the post acknowledges that the legend of Xerox PARC—the oft, oft, oft-repeated story (repeated once again by Gladwell) that … Continue reading “PARC Fires Back at New Yorker, Claiming Old Apple Legend Misses Point of How Innovation Works Today”
Zaarly on Capitol Hill: Why the Startup Ecosystem Matters
On Tuesday, May 10, 2011, I had the opportunity to participate in a hearing convened by the U.S. House of Representatives Committee on Oversight and Government Reform. This was an incredible honor as an entrepreneur to sit on a distinguished panel and speak directly to leaders in the House of Representatives and from the Securities … Continue reading “Zaarly on Capitol Hill: Why the Startup Ecosystem Matters”
Microsoft’s Online Head Qi Lu: Skype Deal Is “Key Addition” of Marquee Consumer Brand
Microsoft’s biggest acquisition to date was on display this week, in Boston. I’m not talking about Skype. I’m talking about Qi Lu. Lu, the president of Microsoft’s online services division, was in town on Wednesday to meet with employees at the firm’s New England Research and Development Center (NERD) in Cambridge, MA, and, in addition … Continue reading “Microsoft’s Online Head Qi Lu: Skype Deal Is “Key Addition” of Marquee Consumer Brand”
Oral Insulin Is Still Very Much Alive at Some New York and Boston Area Biotechs
Earlier this week, I wrote about MonoSolRx, a New Jersey company that hopes to start human trials later this year of an insulin product that’s packaged in an edible film. The film can be stuck to the side of the cheek, where it dissolves and distributes a dosage of insulin—the drug that most patients with … Continue reading “Oral Insulin Is Still Very Much Alive at Some New York and Boston Area Biotechs”
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives
The board of iPierian, the South San Francisco-based stem cell company with high-profile scientific founders from Harvard University and prominent financial backers that include GlaxoSmithKline, Kleiner Perkins Caufield & Byers, Google Ventures, and Biogen Idec, has terminated several members of the company’s senior executive team as part of a shift in strategy, Xconomy has learned. … Continue reading “iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives”
The iPad Finally Has a Worthy Rival: Samsung’s Galaxy Tab 10.1
Apple may be the world’s largest electronics company as measured by market capitalization, but Samsung is the largest by sales. So it makes sense that the Seoul, Korea-based giant—not Microsoft, not HP, not Motorola, not Dell—would the first to compete seriously in the market that Apple invented last year with the introduction of the iPad. … Continue reading “The iPad Finally Has a Worthy Rival: Samsung’s Galaxy Tab 10.1”
Innovating for Education: Puget Sound Businesses Can Lead the Way
Educational reform is at the top of the national agenda, and it is a particularly salient issue for the tech industry. To lead the world in innovation, we also must lead in education. The U.S. already lags behind many other nations in math and science proficiency, and we have fallen to ninth in the proportion … Continue reading “Innovating for Education: Puget Sound Businesses Can Lead the Way”
GSK Backs SpringLeaf, Prexa Nabs $7M from Advent & Shire, Acetylon Gets $5M Partnership, & More Boston-Area Life Sciences News
New England biotechs made headlines this week with partnerships and financing news. —Merrimack Pharmaceuticals, a Cambridge, MA-based drug developer, bought back the rights to market one of its drugs in Europe and Asia from Taiwan-based PharmaEngine. Merrimack paid $10 million upfront and could pay another $210 million in milestones and royalties to develop and commercialize … Continue reading “GSK Backs SpringLeaf, Prexa Nabs $7M from Advent & Shire, Acetylon Gets $5M Partnership, & More Boston-Area Life Sciences News”
MoMelan Technologies Closes $3.5M in Series A Financing
MoMelan Technologies, the developer of a device to treat skin disorders by expanding the surface area of skin grafts, has raised $3.5 million, according to the company’s top executive. MoMelan, based in Cambridge, MA, added KLP Enterprises and Life Science Angels to its existing list of investors, which includes LaunchCapital and Mass Medical Angels. The … Continue reading “MoMelan Technologies Closes $3.5M in Series A Financing”
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News
We had one pretty noteworthy acquisition in the Bio/IT community this week, and a smattering of news items from the world of global health, biotech drugs, and biofuels. —Seattle-based Geospiza, one of the mainstays of the bioinformatics industry, agreed to be acquired by PerkinElmer (NYSE: [[ticker:PKI]]), the giant life sciences toolmaker in Waltham, MA. Terms … Continue reading “Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News”
What Ever Happened To Michigan High Tech IPOs?
Inside the rather stuffy conference rooms at the Marriott Eagle Crest hotel in Ypsilanti, MI, entrepreneur after entrepreneur took to the microphone in 15 minute increments, hoping to win over at least one potential investor. The technologies and strategies they offered varied but their business plans ended the same way: an acquisition by a large … Continue reading “What Ever Happened To Michigan High Tech IPOs?”
As IPO Market Thaws, Carbonite Files to Go Public with Growing Data-Backup Business
Han Solo was once frozen in “carbonite.” Now Boston’s namesake tech company is emerging from a different kind of deep freeze. When we last spoke this winter, David Friend said his online data backup firm, Carbonite, was in the late stages of filing for an IPO. The man is true to his word. Boston-based Carbonite … Continue reading “As IPO Market Thaws, Carbonite Files to Go Public with Growing Data-Backup Business”
Lanyrd: Twitter Meets LinkedIn Meets IMDB for the Conference Circuit
Sixth in a series of profiles of Y Combinator Winter 2011 startups. I’m always on the lookout for technologies that have the potential to help us be better journalists and storytellers, and I find new ones pretty regularly—touchscreen video editing being my favorite recent example. But Xconomy is both a media company and an events … Continue reading “Lanyrd: Twitter Meets LinkedIn Meets IMDB for the Conference Circuit”
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit
On May 11, Shire (NASDAQ: [[ticker:SHPGY]]) CEO Angus Russell told a panel of journalists at the Reuters Health Summit in New York that the British drug giant is interested in pursuing gene therapy and stem cells. Those are two areas of science that have yet to prove they can produce effective, innovative new therapies. Still, over … Continue reading “Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit”
Gamification, Barely a Year Old, Could Implode & Take a New Industry Down With It—Thoughts From Bobber Interactive’s Scott Dodson
These are dizzying days for the business of games. It was almost exactly a year ago that we first wrote about the idea of applying video game features, like rewards and leaderboards, to websites and other connected services. Known as “gamification,” this new niche business aims to increase the amount of time people spend with … Continue reading “Gamification, Barely a Year Old, Could Implode & Take a New Industry Down With It—Thoughts From Bobber Interactive’s Scott Dodson”
Halozyme Deal Could Yield $83M, Wireless Health Leaders Converge, Readers Vote on Worst Drug Names, & More San Diego Life Sciences News
Much of the action this week was taking place downtown, at the 6th annual Convergence Summit hosted by the nonprofit Wireless-Life Sciences Alliance. The three-day conference included CEOs, entrepreneurs, investors, executives, and innovators—and we’ve got the highlights of that and other area life sciences news wrapped up here. —San Diego’s Qualcomm (NASDAQ: QCOM), the largest … Continue reading “Halozyme Deal Could Yield $83M, Wireless Health Leaders Converge, Readers Vote on Worst Drug Names, & More San Diego Life Sciences News”
Matrix Genetics Pursues the Algae Fuel Dream in the Lab, Not With Big Steel Tanks, Giant Ponds
Margaret McCormick has been dreaming of ways to make microorganisms do big things since her grad school days in biology at MIT. Years later, the scientist-turned-venture capitalist is now in a position to act on those dreams as CEO of a Seattle-based startup called Matrix Genetics. The idea is about as big as startup visions … Continue reading “Matrix Genetics Pursues the Algae Fuel Dream in the Lab, Not With Big Steel Tanks, Giant Ponds”
A Startup Rival Offers His Perspective on Enormous Microsoft-Skype Deal
On Tuesday, the sun set in the East. Water ran uphill. And Redmond, WA-based Microsoft agreed to pay $8.5 billion in cash for an Internet company that gives away much of its service for free. The news could only be more de-polarizing if Luxembourg-based Skype Technologies had developed its Internet-based telephone service as open source … Continue reading “A Startup Rival Offers His Perspective on Enormous Microsoft-Skype Deal”
SpringLeaf Snags $15M for New Self-Injection System for Biotech Drugs
The folks at SpringLeaf Therapeutics will not be accused of thinking too small. This quiet little company is stepping up today to declare its pursuit of a pretty bold idea—that it can deliver drugs that are not just safe and effective, but also more cost-effective for the U.S. healthcare system. SpringLeaf Therapeutics, formerly known as … Continue reading “SpringLeaf Snags $15M for New Self-Injection System for Biotech Drugs”
Sanergy Takes 2011 MIT $100K Prize, Audience Choice Award For Its Toilet Sanitation Technology
Sanergy gets kudos for scoring the daily double at tonight’s MIT $100K Entrepreneurship Competition. The team won both the $100,000 grand prize and the audience choice award, for pitching its toilet and sanitation systems that convert human waste to fertilizer and electricity in developing countries. Sanergy, the finalist in the emerging markets track of the … Continue reading “Sanergy Takes 2011 MIT $100K Prize, Audience Choice Award For Its Toilet Sanitation Technology”
Active Network Ready to Pull IPO Trigger
[Corrected 5/20/09, 5:00 pm. See below.] The Active Network is in the starting blocks for its IPO. The San Diego Internet company, which provides online event registration services for sporting event organizers, churches, campgrounds, and other customers, set a price range between $16 and $18 a share for its initial stock offering in a regulatory … Continue reading “Active Network Ready to Pull IPO Trigger”
IntelePeer IPO Could Provide Windfall to EDF Ventures and U-M Wolverine Fund
EDF Ventures and the University of Michigan Wolverine Fund could be looking at a nice pay day. The two funds, based in Ann Arbor, MI, are both investors in IntelePeer, which recently filed for an initial public offering that could fetch up to $100 million, according to documents filed with the SEC. IntelePeer, based in … Continue reading “IntelePeer IPO Could Provide Windfall to EDF Ventures and U-M Wolverine Fund”
At Metcalfe’s Party for MIT $100K Finalists, a Preview of Startups Presenting at Tonight’s Finale
It was high society meets tech entrepreneurship last night. The setting: Bob Metcalfe’s townhouse in the Back Bay. The occasion: an annual reception and dinner before the finale of the MIT $100K Business Plan Contest, which takes place tonight at Kresge Auditorium. The players: all the finalists and event organizers, plus a few venture capitalists … Continue reading “At Metcalfe’s Party for MIT $100K Finalists, a Preview of Startups Presenting at Tonight’s Finale”
Do You Really Need an Incubator? Join the Debate at XSITE on June 16
Although nobody seems to like the term “incubator”—mostly because of failures from the dot-com era—it’s clear that mentorship and accelerator programs like Y Combinator, TechStars, and MassChallenge have taken off in the mainstream consciousness of innovation. They provide lots of coaching, financial support, office space, and connections to investors and other startups. Yet in most … Continue reading “Do You Really Need an Incubator? Join the Debate at XSITE on June 16”
News From the Wireless Health Summit: Topol Plans a Medical School for Techies, the X Prize Plans a Challenge for Trekkies, & FDA Official Shows ‘Telepresence’
Some big names were on the agenda yesterday at the 2011 Convergence Summit, which is being held in a downtown San Diego hotel under the auspices of the nonprofit Wireless-Life Sciences Alliance. A couple of the speakers actually delivered some interesting news: —Qualcomm (NASDAQ: [[ticker:QCOM]]) chairman and CEO Paul Jacobs made the first unexpected announcement … Continue reading “News From the Wireless Health Summit: Topol Plans a Medical School for Techies, the X Prize Plans a Challenge for Trekkies, & FDA Official Shows ‘Telepresence’”
Video Advertising for the Long Tail: Behind Blinkx’s Acquisition of Burst Media
How did Burst Media, a Burlington, MA, company that helped to invent the idea of the online advertising server at the dawn of the dot-com era, end up as part of a San Francisco-based video search company called Blinkx? And how will owning Burst’s network of niche publishing sites change the way Blinkx does business? … Continue reading “Video Advertising for the Long Tail: Behind Blinkx’s Acquisition of Burst Media”
Drugs that Melt in Your Mouth: MonoSolRx Has Its Sights Set on Oral Insulin
[Corrected 5/12/11, 9:00 am. See below.] The sample packets of the anti-nausea drug that are strewn across the desk of Mark Schobel, CEO of MonoSol Rx, don’t look anything like your standard pharmaceutical product. Each dose of the drug, called ondansetron (Zuplenz)—which is prescribed to cancer patients undergoing chemotherapy and other harsh treatments—is a small, … Continue reading “Drugs that Melt in Your Mouth: MonoSolRx Has Its Sights Set on Oral Insulin”
3Tier, Tracking the World’s Hotspots for Alternative Energy, Names New CEO
Seattle-based 3Tier Group, which has developed a map of the world’s best places for wind and solar power, has named Craig Husa as its new chief executive. Founder Kenneth Westrick, who previously served as CEO, remains with the company as chairman. The company announced in December that Westrick was moving away from day-to-day duties. Husa … Continue reading “3Tier, Tracking the World’s Hotspots for Alternative Energy, Names New CEO”
PeerTransfer, Inspired by Raw Deals for International Students, Rolls Out Online Tuition Payment Service
You might call it the perfect up-and-coming Boston tech startup. A mix of higher education, financial services, and a global market. The brainchild of an MIT student entrepreneur. A company with the support of a young, well-connected Boston venture capitalist and many notable angel investors. I’m talking about Cambridge, MA-based peerTransfer, which has 17 employees … Continue reading “PeerTransfer, Inspired by Raw Deals for International Students, Rolls Out Online Tuition Payment Service”
Raising Capital At-The-Market: a Prescription for a Solid Long-Term Financing Strategy
Companies in emerging industries such as the life sciences are constantly looking for funding, but uncertainty in the capital markets has made this a time-sensitive, challenging and expensive process to execute. The capital markets, particularly over the last few years, and especially for research and development-intensive biopharmaceutical companies, have been unpredictable, making timing of financings … Continue reading “Raising Capital At-The-Market: a Prescription for a Solid Long-Term Financing Strategy”
Varian Bought by Applied Materials, Nuance Picks Up Equitrac, Alkermes Pays $960M for Elan Unit, & More Boston-Area Deals News
Acquisitions headlines were big this week in New England, and spanned the semiconductor, life sciences, mobile, and software spaces. —PlumChoice, a Billierica, MA-based provider of remote IT services to businesses, nabbed $25.6 million from new backers M/C Venture Partners, Gold Hill Capital, and Eastward Capital, as well as its previous investors. —Gloucester, MA-based Varian Semiconductor … Continue reading “Varian Bought by Applied Materials, Nuance Picks Up Equitrac, Alkermes Pays $960M for Elan Unit, & More Boston-Area Deals News”
Qualcomm and the X Prize Foundation Move to Energize Diagnostics with $10M ‘Tricorder Prize’
Qualcomm (NASDAQ: [[ticker:QCOM]]) chairman and CEO Paul Jacobs revealed today that the San Diego-based wireless technology giant has been working with the X Prize Foundation to develop criteria for a new $10 million X Prize grand challenge that is straight out of Star Trek—a “Tricorder X Prize.” The idea—which is still being distilled—is to offer … Continue reading “Qualcomm and the X Prize Foundation Move to Energize Diagnostics with $10M ‘Tricorder Prize’”
Boston Scientific Chief to Exit the Stage, Two Years Into Turnaround Bid; Shares Tank
Boston Scientific picked Ray Elliott as the change agent less than two years ago to help turn things around for the medical device giant, and now Elliott is on his way out. The Natick, MA-based company (NYSE: [[ticker:BSX]]) said today that Elliott, 61, informed the board of directors on May 4 that he plans to … Continue reading “Boston Scientific Chief to Exit the Stage, Two Years Into Turnaround Bid; Shares Tank”
Churnless Consults Big Corporations and Incubates Startups Focused on Helping Consumers Change Behavior
Mix one part consultancy with another part incubator and then toss that with an entrepreneur’s passion project. Sprinkle on some academia, too. And there you have New York-based Churnless. The firm’s founders, Matt Wallaert and Avi Karnani, come from Thrive, a company focused helping consumers make better financial decisions. They sold it to Lendingtree.com in … Continue reading “Churnless Consults Big Corporations and Incubates Startups Focused on Helping Consumers Change Behavior”